In The Media
In The News
Stanford professor Kari Nadeau lives the life, some would say the dream, of what Judah Folkman has called the inquisitive physician, integrating her deep knowledge of chemistry, her experience in biotech drug development, and her clinical acumen and deeply-felt compassion for patients to bring the best of medicine and science to children and adults with food allergies.
The Future of Everything with Russ Altman:
Sharon Chinthrajah, a clinical associate professor at the Stanford School of Medicine, explains ways to protect your health from air pollution while decreasing energy consumption.
- An expert advisory panel says a new treatment option for peanut allergies should be approved.
- The medication is called Palforzia and it would be the first drug to target these types of dangerous allergies.
- It is not considered a full cure but a way to reduce dangerous symptoms.
This is example text for the text & image NIH and Partners to Assess Whether Omalizumab Can Reduce Allergic Reactions
Already this summer, the Bay Area has had heat waves topping 100 degrees. Most Americans in the rest of the country are facing extreme heat this week. These dangerous events are becoming more common and are putting clean air, public health and lives at risk. They’re just the latest indicator that we are facing a climate health emergency.
San Francisco Chronicles - July 23, 2019
What’s the difference between charitable giving from ordinary people and philanthropic giving from the very wealthy?
The New York Times - November 16, 2018
The Doctors TV - September 20, 2018
Study Finds Combining Xolair with OIT Led to Quicker, Safer Desensitization with Multiple Food Allergens
Allergic Living - December 12, 2017
It’s been a harrowing journey for 10-year-old Tessa Grosso and her family. Tessa has multiple food allergies, and her severe reactions to even the slightest trace of certain substances could have killed her.